Pomiferin A

Pomiferin A

SCHEMBL1210740

CC(C)c1ccc2c(c1)CC[C@H]1[C@](C)(CO)CCC[C@]21C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KARS1 Q15046 3/20 1.00
▸ CYP3A4 P08684 4/20 0.79
▸ MEN1 O00255 3/20 0.79
▸ KMT2A Q03164 3/20 0.79
▸ TSHR P16473 2/20 0.79
▸ CYP2D6 P10635 2/20 0.79
▸ CYP2C19 P33261 2/20 0.79
▸ PDK1 Q15118 1/20 0.79
▸ PDK2 Q15119 1/20 0.79
▸ PDK3 Q15120 1/20 0.79
▸ PDK4 Q16654 1/20 0.79
▸ CYP2C9 P11712 1/20 0.79
▸ MAPK1 P28482 2/20 0.77
▸ TP53 P04637 1/20 0.77
▸ MAPT P10636 1/20 0.77
▸ ALOX15 P16050 1/20 0.77
▸ RXRA P19793 1/20 0.70
▸ CCNE1 P24864 1/20 0.70
▸ CDK2 P24941 1/20 0.70
▸ RXRB P28702 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pomiferin A SCHEMBL2728630 1.00 KARS1 (1.00) KARS1CYP3A4MEN1KMT2ATSHR
Pomiferin A SCHEMBL30087017 1.00 KARS1 (1.00) KARS1CYP3A4MEN1KMT2ATSHR
Pomiferin A SCHEMBL4549111 1.00 KARS1 (1.00) KARS1CYP3A4MEN1KMT2ATSHR
Pomiferin A SCHEMBL13039025 1.00 KARS1 (1.00) KARS1CYP3A4MEN1KMT2ATSHR
Pomiferin A SCHEMBL2546195 1.00 KARS1 (1.00) KARS1CYP3A4MEN1KMT2ATSHR
SCHEMBL20866442 0.91 KARS1 (0.83) KARS1CYP3A4MEN1KMT2ATSHR
SCHEMBL16298228 0.89 CYP3A4 (0.80) KARS1CYP3A4MEN1KMT2ATSHR
SCHEMBL4943352 0.88 CYP3A4 (1.00) KARS1CYP3A4MEN1KMT2ATSHR
SCHEMBL27863 0.88 CYP3A4 (1.00) KARS1CYP3A4MEN1KMT2ATSHR
SCHEMBL17158674 0.88 CYP3A4 (1.00) KARS1CYP3A4MEN1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4619459-A1 MODIFIED PU FOAM Wenatex Forschung - Entwicklung - Produktion GmbH (AT) 2025-09-24 — — EP claimed
EP-4619578-A2 MODIFIED FIBRE MATERIAL Wenatex Forschung - Entwicklung - Produktion GmbH (AT) 2025-09-24 — — EP claimed
WO-2024103091-A1 MODIFIED PU FOAM WENATEX FORSCHUNG - ENTWICKLUNG - PRODUKTION GMBH (AT) 2024-05-23 — — WO claimed
WO-2024103092-A2 MODIFIED FIBRE MATERIAL WENATEX FORSCHUNG - ENTWICKLUNG - PRODUKTION GMBH (AT) 2024-05-23 — — WO claimed
WO-2023146479-A1 A METHOD FOR PURIFICATION OF ORGANIC WATER-SOLUBLE POLYMERS FROM HYDROPHOBIC CONTAMINANTS USTAV EXPERIMENTALNEJ FYZIKY SLOVENSKEJ AKADEMIE VIED, VEREJNA VYSKUMNA INSTITUCIA (SK) 2023-08-03 — — WO claimed
EP-4219603-A1 A METHOD FOR PURIFICATION OF ORGANIC WATER-SOLUBLE POLYMERS FROM HYDROPHOBIC CONTAMINANTS Ustav experimentálnej fyziky SAV, v.v.i. (SK) 2023-08-02 — — EP claimed
CN-106566595-A Phosphorus-free sulfur-free anti-wear lubricating oil additive, engine lubricating oil and preparation method of phosphorus-free sulfur-free anti-wear lubricating oil additive 南京悠谷知识产权服务有限公司 2017-04-19 — — CN claimed
CN-104610053-B A kind of scaling powder rosin derivative and preparation method INSTITUTE OF CHEMICAL INDUSTRY OF FOREST PRODUCTS, CHINESE ACADEMY OF FORESTRY (CN) 2016-05-25 — — CN claimed
CN-103965373-B (2-hydroxyl-3-dehydrogenation fir oxygen base) propyl group chitooligosaccharide-and preparation method thereof YANGCHENG INSTITUTE OF TECHNOLOGY (CN) 2016-02-24 — — CN claimed
CN-103923228-B (2-hydroxyl-3-dehydrogenation fir oxygen base) hydroxypropyl hydroxyethyl chitosan and preparation method thereof YANGCHENG INSTITUTE OF TECHNOLOGY (CN) 2016-02-10 — — CN claimed
CN-104610053-A Rosin derivate for soldering flux and preparation method INST CHEM IND FOREST PROD CAF 2015-05-13 — — CN claimed
CN-104558019-A Halogen-free rosin-based flame retardant and preparation method thereof GUANGXI KEMAO FOREST CHEMICAL CO LTD 2015-04-29 — — CN claimed
US-8916031-B2 Recovery of tetracosanol from a mixture derived from tall oil pitch PONTIFICIA UNIVERSIDAD CATOLICA DE VALPARAISO (CL) 2014-12-23 — — US claimed
CN-103965373-A (2-hydroxy-3-dehydroabieticoxy) propyl chitosan-oligosaccharide and preparation method thereof YANCHENG INST TECHNOLOGY 2014-08-06 — — CN claimed
CN-103923228-A (2-hydroxyl-3-dehydrofiroxy) propyl ethoxyl chitosan and preparation method thereof YANCHENG INST TECHNOLOGY 2014-07-16 — — CN claimed
US-20120125762-A1 RECOVERY OF TETRACOSANOL FROM A MIXTURE DERIVED FROM TALL OIL PITCH HARTING S.A. (CL) 2012-05-24 — — US claimed
CN-101657472-A Use of nonionic surfactants as emulsifiers in emulsion polymerization COGNIS IP MAN GMBH DE 2010-02-24 — — CN claimed
EP-4619459-A1 MODIFIED PU FOAM Wenatex Forschung - Entwicklung - Produktion GmbH (AT) 2025-09-24 — — EP disclosed
US-20070190192-A1 Novel abietane diterpenoid compound, and composition comprising extract of torreya nucifera, or abietane diterpenoid compounds or terpenoid compounds isolated from them for prevention and treatment of cardiovascular disease KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND (KR) 2007-08-16 — — US disclosed
WO-2005084141-A2 NOVEL ABIETANE DITERPENOID COMPOUND, AND COMPOSITION COMPRISING EXTRACT OF TORREYA NUCIFERA, OR ABIETANE DITERPENOID COMPOUNDS OR TERPENOID COMPOUNDS ISOLATED FROM THEM FOR PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASE KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2005-09-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070190192-A1 Novel abietane diterpenoid compound, and composition comprising extract of torreya nucifera, or abietane diterpenoid compounds or terpenoid compounds isolated from them for prevention and treatment of cardiovascular disease ACAT1, ACAT2, LCAT KARS1 3287/4885CYP3A4 1992/4885MEN1 4248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback